基于顾客满意的IRS企业营销策略研究.doc

英国威尔士大学 工商管理硕士(MBA)论文 DECLARATION I hereby declare that this work has not previously been accepted in substance for any degree and is not being concurrently submitted in candidature for any degree. This dissertation is being submitted in partial fulfillment of the requirements for the degree of MBA. It is the results of my own independent work/investigation, except where otherwise stated. Other sources are acknowledged by giving explicit reference and a bibliography is appended. I also give consent for my dissertation, if accepted, to be available for photocopying and for inter-library loan, and for the title and abstract to be made available to outside organizations. Candidate(Full Name): Signature: Date:摘要 IRS公司是从上海起家，辐射全国的一家中大型医疗设备提供商。2004年5月成立，注册资本600万元人民币2005年10月，增资至1000万元人民币（合129万美元）。有限公司主要研发、生产和销售放疗、热疗等大型肿瘤治疗设备。公司2004年12月份推出了目前世界上最先进的肿瘤精确放疗设备，该产品已于2006年3月获得中国国家食品药品监督管理局（SFDA）的生产许可证，截至200年底，公司已签订43份产品的租赁和销售合同。截止200年底，公司预收货款3860万元人民币。将全球市场划分为10个大区，并拟在公司下设10个大区管理部。目前，中国大区管理部已经成立，其余9个大区管理部正在筹建中。 IRS is started from Shanghai, radiation in a large-scale nationwide provider of medical equipment. Established in May 2004, the registered capital of six million yuan, in October 2005, increase to 1000 million yuan (1.29 million U.S. dollars). IRS Co., Ltd. is mainly engaged in RD, production and marketing of radiotherapy, hyperthermia treatment equipment and other large tumor. In December 2004 the company launched the worlds most advanced precise radiotherapy equipment tumor GK60, the product had been received the production license from Chinas State Food and Drug Administration (SFDA) in March 2006. At the end of 2007, the company has entered into 43 GK60 and related products, leasing and sales contracts. Also the company paid 38.6 million yuan in advance. IRS divided the global market into 10 regions, and 10 companys regions management Department. At present, China has set up District Management, and the remaining nine regions are planning for the Central Manag